See also this year's filing and all EDGAR filings for this company.
PDF Report 0001582554_2023_Matinas_BioPharma_Holdings_Inc.pdf
Logs
Graph
Absolute values for 0001582554, Matinas BioPharma Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 34,532,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,353,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,091,000 |
| 3 | remainder_Assets | 3,843,000 |
| 4 | LiabilitiesCurrent | 4,286,000 |
| 5 | LiabilitiesNoncurrent | 3,896,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,100,000 |
| 9 | ResearchAndDevelopmentExpense | 16,678,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,188,000 |
| 12 | remainder_NetIncome | 3,593,000 |
| 13 | remainder_ComprehensiveNetIncome | -679,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 44,819,000 |
| 1 | Liabilities | 8,182,000 |
| 2 | Expenses | 27,778,000 |
| 3 | Revenues | 3,188,000 |
| 4 | StockholdersEquity | 36,637,000 |
| 5 | NetIncome | -20,997,000 |
| 6 | ComprehensiveNetIncome | -21,336,500 |
| 7 | BaseVar | 44,119,500 |
| 8 | EconomicCapitalRatio | 1.57 |